Who Paid My Doc
Modupe Odugbemi
Registered Nurse, Medical-Surgical Bronx, NY Nurse Practitioner
NPI 1265976559 CMS profile 10837338
3424 Kossuth Ave, Bronx, NY 10467
General payments
$489
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Modupe Odugbemi of Bronx, NY is reported in the CMS Open Payments database as having received $489 across 6 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $158 | 3 | |
| 2024 | General | $64 | 1 | |
| 2023 | General | $150 | 1 | |
| 2022 | General | $118 | 1 |
Beside peers
- Modupe Odugbemi
- Registered Nurse, Medical-Surgical median
- Middle half of Registered Nurse, Medical-Surgical
- National median
In program year 2025, general payments to Modupe Odugbemi were reported at $158. Among 51 Registered Nurse, Medical-Surgical profiles paid that year, the median was $94 and the middle half received between $25 and $256.
Show as a table
| Year | Modupe Odugbemi | Registered Nurse, Medical-Surgical median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $98 | $20–$177 | $132 |
| 2022 | $118 | $120 | $27–$174 | $149 |
| 2023 | $150 | $94 | $31–$243 | $160 |
| 2024 | $64 | $57 | $26–$265 | $164 |
| 2025 | $158 | $94 | $25–$256 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 29 drugsPart D claims
815
Drug cost
$137,732
Branded share of claims
33.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | Brand | 42 | $36,886 | |
| Ozempic Semaglutide | Brand | 16 | $29,104 | |
| Januvia Sitagliptin Phosphate | Brand | 25 | $21,581 | |
| Trulicity Dulaglutide | Brand | 12 | $21,318 | |
| Eliquis Apixaban | Brand | 11 | $10,793 | |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | Brand | 17 | $6,912 | |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | Brand | 22 | $1,903 | |
| Novolog Flexpen Insulin Aspart | Brand | 12 | $1,470 | |
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 45 | $1,462 | |
| Atorvastatin Calcium | Generic | 100 | $1,428 |
The 10 drugs with the highest cost, of 29 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 476 Part D prescribers listed as Registered Nurse; they describe a distribution and say nothing about conduct.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Registered Nurse, Medical-Surgical in New York
Alexandra Martino
Registered Nurse, Medical-Surgical · Patchogue, NY
Stephanie Porter
Registered Nurse, Medical-Surgical · Huntington, NY
Elissa Bruzga
Registered Nurse, Medical-Surgical · Patchogue, NY
Lisa Torrieri
Registered Nurse, Medical-Surgical · Nanuet, NY
Michelle Romano
Registered Nurse, Medical-Surgical · Farmingville, NY
Kikelomo Ejiogu
Registered Nurse, Medical-Surgical · Far Rockaway, NY
Related records
Registered Nurse, Medical-Surgical in New York
Practitioners in the same specialty and state, ranked by reported value.
All Registered Nurse, Medical-Surgical
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.